Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study

[1]  A. Chanan-Khan,et al.  Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis. , 2020, Clinical lymphoma, myeloma & leukemia.

[2]  M. Boccadoro,et al.  Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients , 2020, Cancers.

[3]  M. Drayson,et al.  Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial , 2019, The Lancet. Oncology.

[4]  A. Rambaldi,et al.  Effect of novel agents on the risk of early death of newly diagnosed symptomatic multiple myeloma patients: A single Centre retrospective analysis , 2018, American journal of hematology.

[5]  M. Boccadoro,et al.  Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis. , 2018, Critical reviews in oncology/hematology.

[6]  L. Trippa,et al.  A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma , 2018, British journal of haematology.

[7]  Shankar Srinivasan,et al.  Recognition of early mortality in multiple myeloma by a prediction matrix , 2017, American journal of hematology.

[8]  J. Cheong,et al.  Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen , 2016, BMC Cancer.

[9]  C. Teng,et al.  Early mortality in multiple myeloma: Experiences from a single institution , 2016, Hematology.

[10]  U. Mellqvist,et al.  Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients , 2015, Haematologica.

[11]  H. Goldschmidt,et al.  International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. , 2014, The Lancet. Oncology.

[12]  S. Vincent Rajkumar,et al.  Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients , 2013, Leukemia.

[13]  P. Sonneveld,et al.  Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials , 2013, Haematologica.

[14]  G. Morgan,et al.  Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.